These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34702727)

  • 1. Improving early diagnosis of cardiovascular disease in patients with type 2 diabetes and COPD: protocol of the RED-CVD cluster randomised diagnostic trial.
    Groenewegen A; Zwartkruis VW; Rienstra M; Hollander M; Koffijberg H; Cramer MJM; van der Schouw YT; Hoes AW; de Boer RA; Rutten FH
    BMJ Open; 2021 Oct; 11(10):e046330. PubMed ID: 34702727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic yield of a proactive strategy for early detection of cardiovascular disease versus usual care in adults with type 2 diabetes or chronic obstructive pulmonary disease in primary care in the Netherlands (RED-CVD): a multicentre, pragmatic, cluster-randomised, controlled trial.
    Groenewegen A; Zwartkruis VW; Rienstra M; Zuithoff NPA; Hollander M; Koffijberg H; Oude Wolcherink M; Cramer MJ; van der Schouw YT; Hoes AW; Rutten FH; de Boer RA
    Lancet Public Health; 2024 Feb; 9(2):e88-e99. PubMed ID: 38134944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility study of a multicentre cluster randomised control trial to investigate the clinical and cost-effectiveness of a structured diagnostic pathway in primary care for chronic breathlessness: protocol paper.
    Doe G; Clanchy J; Wathall S; Chantrell S; Edwards S; Baxter N; Jackson D; Armstrong N; Steiner M; Evans RA
    BMJ Open; 2021 Nov; 11(11):e057362. PubMed ID: 34815293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: protocol of a randomised controlled proof-of-concept trial (APPLE COPD-ICON 2).
    Kunadian V; Chan D; Ali H; Wilkinson N; Howe N; McColl E; Thornton J; von Wilamowitz-Moellendorff A; Holstein EM; Burns G; Fisher A; Stocken D; De Soyza A;
    BMJ Open; 2018 May; 8(5):e020713. PubMed ID: 29804061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a specialist palliative home care nurse-patient consultation followed by an interprofessional telephone case conference compared with usual care among patients with non-oncological palliative care needs: protocol for the multicentre KOPAL cluster-randomised controlled trial.
    Marx G; Mallon T; Pohontsch NJ; Schade F; Dams J; Zimansky M; Asendorf T; Böttcher S; Mueller CA; Freitag M; Hummers E; van den Bussche H; Schäfer I; König HH; Stiel S; Schneider N; Nauck F; Friede T; Scherer M
    BMJ Open; 2022 Jul; 12(7):e059440. PubMed ID: 35879008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pragmatic cluster randomized controlled trial of early intervention for chronic obstructive pulmonary disease by practice nurse-general practitioner teams: Study Protocol.
    Bunker JM; Reddel HK; Dennis SM; Middleton S; Van Schayck C; Crockett AJ; Hasan I; Hermiz O; Vagholkar S; Marks GB; Zwar NA
    Implement Sci; 2012 Sep; 7():83. PubMed ID: 22958678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening.
    Webb DR; Khunti K; Srinivasan B; Gray LJ; Taub N; Campbell S; Barnett J; Henson J; Hiles S; Farooqi A; Griffin SJ; Wareham NJ; Davies MJ
    Trials; 2010 Feb; 11():16. PubMed ID: 20170482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interdisciplinary model of care (RADICALS) for early detection and management of chronic obstructive pulmonary disease (COPD) in Australian primary care: study protocol for a cluster randomised controlled trial.
    Liang J; Abramson MJ; Zwar N; Russell G; Holland AE; Bonevski B; Mahal A; Hecke BV; Phillips K; Eustace P; Paul E; Petrie K; Wilson S; George J
    BMJ Open; 2017 Sep; 7(9):e016985. PubMed ID: 28928190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated management of atrial fibrillation including tailoring of anticoagulation in primary care: study design of the ALL-IN cluster randomised trial.
    van den Dries CJ; Oudega R; Elvan A; Rutten FH; van de Leur SJCM; Bilo HJG; Hoes AW; Moons KGM; Geersing GJ
    BMJ Open; 2017 Sep; 7(9):e015510. PubMed ID: 28928175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a long-term home-based exercise training programme using minimal equipment vs. usual care in COPD patients: a study protocol for two multicentre randomised controlled trials (HOMEX-1 and HOMEX-2 trials).
    Frei A; Radtke T; Dalla Lana K; Braun J; Müller RM; Puhan MA
    BMC Pulm Med; 2019 Mar; 19(1):57. PubMed ID: 30823913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.
    Francis NA; Gillespie D; White P; Bates J; Lowe R; Sewell B; Phillips R; Stanton H; Kirby N; Wootton M; Thomas-Jones E; Hood K; Llor C; Cals J; Melbye H; Naik G; Gal M; Fitzsimmons D; Alam MF; Riga E; Cochrane A; Butler CC
    Health Technol Assess; 2020 Mar; 24(15):1-108. PubMed ID: 32202490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPACE FOR COPD delivered as a maintenance programme on pulmonary rehabilitation discharge: protocol of a randomised controlled trial evaluating the long-term effects on exercise tolerance and mental well-being.
    Alqahtani KA; Gerlis C; Nolan CM; Gardiner N; Szczepura A; Man W; Singh SJ; Houchen-Wolloff L
    BMJ Open; 2022 Apr; 12(4):e055513. PubMed ID: 35470190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shufeng Jiedu capsule for acute exacerbation of chronic obstructive pulmonary disease: a protocol of multicentre, randomised, double-blind, placebo-controlled trial.
    Xia R; Fei Y; Zhang L; Jie Z; Fan X; Dai M; Moore M; Willcox M; Hu X; Francis N; Liang C; Fei G; Liu J
    BMJ Open; 2023 Sep; 13(9):e070864. PubMed ID: 37775286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and cost-effectiveness of the Assessment of Burden of Chronic Conditions (ABCC) tool in patients with COPD, asthma, diabetes mellitus type 2 and heart failure: protocol for a pragmatic clustered quasi-experimental study.
    Boudewijns EA; Claessens D; Joore M; Keijsers LCEM; van Schayck OCP; Winkens B; Gidding-Slok AHM
    BMJ Open; 2020 Nov; 10(11):e037693. PubMed ID: 33203626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.
    Lenferink A; Brusse-Keizer M; van der Valk PD; Frith PA; Zwerink M; Monninkhof EM; van der Palen J; Effing TW
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011682. PubMed ID: 28777450
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.